A Study of Daily Living Activity Levels in Patients with Total Hip Replacement
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 10-008096
Sponsor Protocol Number: 10-008096
About this study
The purpose of this study is to assess daily living activity levels of patients before and after total hip replacement, and to correlate these activities of daily living to those usually obtained with disease-specific questionnaires.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Male or Female patients
- Ages 20 to 85
- With unilateral osteoarthritis (DJD) who are surgical candidates for total hip arthroplasty
- Study participants must be able to give informed consent
Exclusion Criteria:
- Significant proximal femoral deformity (post SCFE, Perthes, DDH)
- Acetabular dysplasia (ANY CROWE)
- Inflammatory arthritis
- Septic arthritis
- Osteomyelitis
- Prior infection of hip joint
- Significant leg length discrepancy (>4cm)
- Osteoporosis
- Arthrodesis of the affected hip
- The presence of infections, highly communicable diseases, e.g. AIDS, active tuberculosis, venereal disease, hepatitis
- Significant neurological or musculoskeletal disorder or disease that may adversely affect normal gait or weight bearing
- Presence of previous prosthetic hip replacement device (any type) in the operative hip
- Active Metastatic disease
- Active major Psychiatric illness
- Active Drug or alcohol abuse
- BMI > 40
- Patients that are known to be pregnant
- Actively failing contralateral hip replacement
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Kenton Kaufman, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available